Characteristics of individuals with incident MBL
| . | Categories . | No. of individuals with no MBL at baseline screening (n = 264) . | No. of those with incident MBL (n = 60) . |
|---|---|---|---|
| Sex | Male | 105 | 32 (30%) |
| Female | 159 | 23 (18%) | |
| Flow cytometry laboratory (first screening, last screening) | Mayo, Mayo | 136 | 22 (16%) |
| Duke, Mayo | 36 | 13 (36%) | |
| Duke, Duke | 43 | 0 (0%) | |
| US Food and Drug Administration, Mayo | 49 | 25 (51%) | |
| Age at last screening, y | Median (range) | 63 (43-92) | 65 (43-86) |
| Age categories at last screening, y | 40-49 | 25 | 3 (12%) |
| 50-59 | 79 | 15 (19%) | |
| 60-69 | 85 | 24 (28%) | |
| 70-79 | 42 | 12 (29%) | |
| 80+ | 33 | 6 (18%) | |
| Dominant MBL type | CLL-like | 54 (90%) | |
| Atypical | 3 (5%) | ||
| Non–CLL-like | 3 (5%) | ||
| Absolute B-cell count, cells per μL, (n = 60) | Median (range) | 127.0 (21.1-1819.8) | |
| Absolute clonal B-cell count, cells per μL, CLL-like (n = 105) | Median (range) | 2.3 (0.3-1712.7) | |
| Absolute clonal B-cell count, cells per μL, atypical | Median (range) | 0.7 (0.6-11.3) | |
| Absolute clonal B-cell count, cells per μL, non–CLL-like | Median (range) | 137.6 (13.0-232.5) |
| . | Categories . | No. of individuals with no MBL at baseline screening (n = 264) . | No. of those with incident MBL (n = 60) . |
|---|---|---|---|
| Sex | Male | 105 | 32 (30%) |
| Female | 159 | 23 (18%) | |
| Flow cytometry laboratory (first screening, last screening) | Mayo, Mayo | 136 | 22 (16%) |
| Duke, Mayo | 36 | 13 (36%) | |
| Duke, Duke | 43 | 0 (0%) | |
| US Food and Drug Administration, Mayo | 49 | 25 (51%) | |
| Age at last screening, y | Median (range) | 63 (43-92) | 65 (43-86) |
| Age categories at last screening, y | 40-49 | 25 | 3 (12%) |
| 50-59 | 79 | 15 (19%) | |
| 60-69 | 85 | 24 (28%) | |
| 70-79 | 42 | 12 (29%) | |
| 80+ | 33 | 6 (18%) | |
| Dominant MBL type | CLL-like | 54 (90%) | |
| Atypical | 3 (5%) | ||
| Non–CLL-like | 3 (5%) | ||
| Absolute B-cell count, cells per μL, (n = 60) | Median (range) | 127.0 (21.1-1819.8) | |
| Absolute clonal B-cell count, cells per μL, CLL-like (n = 105) | Median (range) | 2.3 (0.3-1712.7) | |
| Absolute clonal B-cell count, cells per μL, atypical | Median (range) | 0.7 (0.6-11.3) | |
| Absolute clonal B-cell count, cells per μL, non–CLL-like | Median (range) | 137.6 (13.0-232.5) |